SBK Financial’s ANI Pharmaceuticals ANIP Stock Holding History
Bought
Maintained
Sold
Other funds holding ANIP
SBK Financial's ANIP Position: Q2 2026 in Review
SBK Financial sold out of ANI Pharmaceuticals (ANIP) in Q2 2026, closing a stake of 42 shares — an estimated $3.23K sold.
SBK Financial first reported a position in ANIP in Q1 2026 and held it in 1 quarter. The position peaked at $3.23K in Q1 2026. 307 funds tracked by Wall St. Rank hold ANIP as of Q2 2026.
- SBK Financial reported no remaining ANI Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
- SBK Financial sold 42 ANI Pharmaceuticals shares in Q2 2026, an estimated $3.23K.
- SBK Financial first reported a position in ANI Pharmaceuticals in Q1 2026 and held it in 1 quarter.
- SBK Financial's ANI Pharmaceuticals position peaked at $3.23K in Q1 2026.
- 307 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q2 2026.
Based on SBK Financial's 13F filing for Q2 2026, filed 2 Nov 2026.